Pharmaceutical Industry Research Report, Pharma Market

sale

Cefetamet Pivoxil Tablets Market

U

2025

Cefetamet Pivoxil Tablets Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Cefetamet is an antibacterial broad spectrum Cephalosporin antibiotic prescribed for susceptible infections. Cefetamet has in-vitro activity against bacteria, such as Haemophilus influenza, Streptococcus pneumoniae, Moraxella catarrhalis, and others, by inhibiting bacterial cell wall synthesis.

Report Code : A03628 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Chlorpheniramine Maleate Market

P

2023

Chlorpheniramine Maleate Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The chlorpheniramine maleate market was valued at $468.6 million in 2022, and is projected to reach $751.4 million by 2032, growing at a CAGR of 4.9% from 2023 to 2032.

Report Code : A03630 | Pages : 438 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. AntiCoagulants Market

U

2022

U.S. AntiCoagulants Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Anticoagulants are used to treat blood clotting. Blood clots are formed when platelets aggregate and protein binds to form a solid mass. However, blood clotting is essential to stop excessive bleeding in diseases such as hemophilia. Anticoagulants are used to treat clot formation by stopping the platelets aggregation.

Report Code : A03638 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

23-Valent Pneumococcal Polysaccharide Vaccine Market

U

2025

23-Valent Pneumococcal Polysaccharide Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Pneumococcal is an infectious disease caused by the streptococcus pneumoniae bacteria. Pneumococcal may cause different types of illnesses such as ear infection, meningitis, and others. There are vaccines ...

Report Code : A03640 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Vitamin A Market

U

2025

Vitamin A Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Vitamin A is also known as retinol, which is a fat-soluble vitamin used for ophthalmic disorders such as cataract, myopia, hypermetropia, presbyopia, night blindness, and retinitis pigmentosa. In ...

Report Code : A03643 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Alexipharmic Drugs Market

U

2025

Alexipharmic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Alexipharmic drugs work as an antidote and are employed to ward off effects of previously administered medications and drug poisoning, it can also be used as a defense against various types if microbial infections.

Report Code : A03650 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Cannabis Pharmaceutical Market

U

2025

Cannabis Pharmaceutical Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Cannabis is used for the treatment of various conditions and diseases and are obtained from either marijuana plants or chemicals.

Report Code : A10262 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Antacids Market

P

2023

Antacids Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global antacids market was valued at $6.7 billion in 2022, and is projected to reach $9.1 billion by 2032, growing at a CAGR of 3.1% from 2023 to 2032.

Report Code : A10281 | Pages : 249 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Telmisartan Market

P

2021

Telmisartan Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

The global telmisartan market size was valued at $3,453 million in 2019, and is projected to reach $4,258 million by 2027, registering a CAGR of 3.4% from 2020 to 2027.

Report Code : A10293 | Pages : 225 | Category : Life Sciences

Price:

~~$3,456~~ $2,696 (22% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

L-Tryptophan Market

U

2025

L-Tryptophan Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

L-tryptophan is an essential amino acid obtained from plant and animal sources, which plays an important role in protein synthesis. The human body does not synthesize L-tryptophan naturally, ...

Report Code : A03654 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Nifedipine Market

U

2025

Nifedipine Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries. Nifedipine is used ...

Report Code : A03658 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Pulmonary Hypertension Drug Market

U

2025

Pulmonary Hypertension Drug Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Pulmonary hypertension is a state of the body in which the blood pressure rises in the arteries. Pulmonary hypertension drugs belong to the class of anti-hypertensives drugs that ...

Report Code : A03661 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Acute Coronary Syndrome (ACS) Market

U

2025

Acute Coronary Syndrome (ACS) Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Acute coronary syndrome refers to the clinical condition in which there is a decrease in the blood flow through the coronary arteries due to improper functioning of the ...

Report Code : A03693 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

ADME Toxicology Testing Market

U

2025

ADME Toxicology Testing Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

ADME refers to the absorption, distribution, metabolism, and elimination of the drugs or chemicals in the body. ADME testing plays a vital role in the drug development process. The testing enables pharmaceutical companies to reduce their drug discovery time, cost, and test complications.

Report Code : A03694 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Biologics and Biosimilars Market

U

2025

Biologics and Biosimilars Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Biologics therapeutics drugs are genetically engineered proteins derived from human genetic material. Biologics therapeutics contains sugars, proteins, or nucleic acids or complex combinations of these substances, or may ...

Report Code : A03701 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Wound Care Biologics Market

P

2023

Wound Care Biologics Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global wound care biologics market was valued at $1.8 billion in 2022, and is projected to reach $3.3 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032.

Report Code : A10347 | Pages : 255 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Vertebroplasty and Kyphoplasty Market

P

2022

Vertebroplasty and Kyphoplasty Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global vertebroplasty and kyphoplasty market was valued at $757.1 million in 2021, and is projected to reach $1,308.1 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031.

Report Code : A10444 | Pages : 183 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Nanotechnology Drug Delivery Market

P

2023

Nanotechnology Drug Delivery Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global nanotechnology drug delivery market was valued at $87.5 billion in 2022, and is projected to reach $209.5 billion by 2032, growing at a CAGR of 9.1% from 2023 to 2032.

Report Code : A10459 | Pages : 245 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Duchenne Muscular Dystrophy Therapeutics Market

U

2025

Duchenne Muscular Dystrophy Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Duchenne muscular dystrophy (DMD) therapeutics helps treat genetic disorder caused due to absence of dystrophin, a protein in the body. The symptoms of the disease include weakness in the muscles of the hips, pelvic area, thighs, and shoulders, and later in the muscles of arms, legs, and trunk.

Report Code : A03755 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Myocardial Infarction Drugs Market

U

2025

Myocardial Infarction Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Myocardial infarction, commonly known as heart attack, occurs due to reduced blood flow to a part of the heart, causing damage to the heart muscle. The medications, which ...

Report Code : A03777 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Japan Generic Drugs Market

U

2022

Japan Generic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Generic drugs are pharmaceutical drugs with similar chemical makeup of a branded drug. Generic drugs are cheaper in Japan and equivalent to branded drugs in dosage, strength, route ...

Report Code : A03804 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Gastroparesis Drugs Market

P

2017

Gastroparesis Drugs Market:

The Global Gastroparesis Market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis ...

Report Code : A03806 | Pages : 231 | Category : Life Sciences

Price:

~~$3,565~~ $2,068 (42% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Acyclovir Market

U

2025

Acyclovir Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Acyclovir is an antiviral medication that is used to treat infections caused by the herpes simplex virus. There are also few side effects caused by them such as nausea and diarrhea.

Report Code : A03821 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Antiplatelet Market

P

2023

Antiplatelet Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global antiplatelet market was valued at $3.8 billion in 2022, and is projected to reach $5.8 billion by 2032, growing at a CAGR of 4.2% from 2023 to 2032.

Report Code : A10479 | Pages : 259 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Epidermal Nevus Syndrome Market

U

2025

Epidermal Nevus Syndrome Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Epidermal nevus syndromes (ENSs) are a group of rare complex disorders characterized by the presence of skin lesions known as epidermal nevi associated with additional extra-cutaneous abnormalities,

Report Code : A10490 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

Pharmaceuticals

Filter by Region

Filter by Discounts

Filter by Category

Cefetamet is an antibacterial broad spectrum Cephalosporin antibiotic prescribed for susceptible infections. Cefetamet has in-vitro activity against bacteria, such as Haemophilus influenza, Streptococcus pneumoniae, Moraxella catarrhalis, and others, by inhibiting bacterial cell wall synthesis.

The chlorpheniramine maleate market was valued at $468.6 million in 2022, and is projected to reach $751.4 million by 2032, growing at a CAGR of 4.9% from 2023 to 2032.

Pneumococcal is an infectious disease caused by the streptococcus pneumoniae bacteria. Pneumococcal may cause different types of illnesses such as ear infection, meningitis, and others. There are vaccines ...

Vitamin A is also known as retinol, which is a fat-soluble vitamin used for ophthalmic disorders such as cataract, myopia, hypermetropia, presbyopia, night blindness, and retinitis pigmentosa. In ...

Alexipharmic drugs work as an antidote and are employed to ward off effects of previously administered medications and drug poisoning, it can also be used as a defense against various types if microbial infections.

Cannabis is used for the treatment of various conditions and diseases and are obtained from either marijuana plants or chemicals.

The global antacids market was valued at $6.7 billion in 2022, and is projected to reach $9.1 billion by 2032, growing at a CAGR of 3.1% from 2023 to 2032.

The global telmisartan market size was valued at $3,453 million in 2019, and is projected to reach $4,258 million by 2027, registering a CAGR of 3.4% from 2020 to 2027.

L-tryptophan is an essential amino acid obtained from plant and animal sources, which plays an important role in protein synthesis. The human body does not synthesize L-tryptophan naturally, ...

Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries. Nifedipine is used ...

Pulmonary hypertension is a state of the body in which the blood pressure rises in the arteries. Pulmonary hypertension drugs belong to the class of anti-hypertensives drugs that ...

Acute coronary syndrome refers to the clinical condition in which there is a decrease in the blood flow through the coronary arteries due to improper functioning of the ...

ADME refers to the absorption, distribution, metabolism, and elimination of the drugs or chemicals in the body. ADME testing plays a vital role in the drug development process. The testing enables pharmaceutical companies to reduce their drug discovery time, cost, and test complications.

Biologics therapeutics drugs are genetically engineered proteins derived from human genetic material. Biologics therapeutics contains sugars, proteins, or nucleic acids or complex combinations of these substances, or may ...

The global wound care biologics market was valued at $1.8 billion in 2022, and is projected to reach $3.3 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032.

The global vertebroplasty and kyphoplasty market was valued at $757.1 million in 2021, and is projected to reach $1,308.1 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031.

The global nanotechnology drug delivery market was valued at $87.5 billion in 2022, and is projected to reach $209.5 billion by 2032, growing at a CAGR of 9.1% from 2023 to 2032.

Duchenne muscular dystrophy (DMD) therapeutics helps treat genetic disorder caused due to absence of dystrophin, a protein in the body. The symptoms of the disease include weakness in the muscles of the hips, pelvic area, thighs, and shoulders, and later in the muscles of arms, legs, and trunk.

Myocardial infarction, commonly known as heart attack, occurs due to reduced blood flow to a part of the heart, causing damage to the heart muscle. The medications, which ...

Generic drugs are pharmaceutical drugs with similar chemical makeup of a branded drug. Generic drugs are cheaper in Japan and equivalent to branded drugs in dosage, strength, route ...

The Global Gastroparesis Market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis ...

Acyclovir is an antiviral medication that is used to treat infections caused by the herpes simplex virus. There are also few side effects caused by them such as nausea and diarrhea.

The global antiplatelet market was valued at $3.8 billion in 2022, and is projected to reach $5.8 billion by 2032, growing at a CAGR of 4.2% from 2023 to 2032.

Epidermal nevus syndromes (ENSs) are a group of rare complex disorders characterized by the presence of skin lesions known as epidermal nevi associated with additional extra-cutaneous abnormalities,